Here I present to you exclusively an undervalued share that few analysts have on their radar. The Cel-Sci share has recovered significantly from its lows reached in 2023 and formed a wave 1. There has been a correction, so we can expect big upward waves 3 and 5 soon. From an option sentiment perspective, the stock is overly bearish. However, an overly negative...
High risk trade to upside but I like it Trend line tested
1Y RSI is trending down. MFI is trending down. -Both have reached a top. 5Y RSI is trending up. MFI is trending up. -Both have bottomed. ALL RSI is reaching a bottom. MFI is trending down. There is a gap around $0.80 and $1. Prediction: I think we will continue falling near the $0.80 and $1 range. Once RSI on the 1Y reaches a bottom it could be poised for an uptrend.
Disclaimer I am very invested in CVM, for a multitude of reasons, first as a scientist, second as an investor, third as my ego. I believe their recent clinical trial results are phenomenal, and illustrate it's potential as the pre-treatment for cancer in immuno-competent patients with appropriate genotypical and phenotypical screening. The clinical trial poster...
Price tested 4 fibonacci levels to close just under the .78 level. In addition the MACD just crossed on the daily. Looks like $12.21 may act as resistance, in which case we may see a retracement to the $11.80-$11.22 level. Target: $13.01 short term. $14.26-$16.71 possible if it starts to squeez.
Disclaimer I am long $CVM to the tune of X0,000 shares (and growing). I genuinely believe, as a scientist, biochemist, and analyst, in Cel-Sci Corporation's Multikine. This article serves as the thesis that $CVM deserves that I have given to other stocks. As always buy shares, options are dangerous and are often used to manipulate the stock. Now that we have...
**SMALL ACCOUNT FRIENDLY PLAY** Peep this insane chart! **CVM** Long above $12.50 Short below $11.22 $SPY $CVM
Disclaimer General disclaimer here. Short but sweet, we have sustained breakout from the bear pennant, we have a dwindling short pool (460k as of today borrowable from Fidelity, down from ~600k on Monday). Less kick in the shorts, and they have until the 20th of this month to sustain the price channel and try to get it under 7.5. Meanwhile, more and more...
Disclaimer Not financial advice, blah blah blah. Looking towards the end of current pennant into a gamma squeeze... Options for 8/20 look like a massive gamma at 10 possible, with another big jump at 12.5 and 15. We could see a massive impulse up with intense gamma pressure from ~1.2 million shares in calls at 10, and another ~700-800k between now and 20. All...
This is an open letter to all large institutional investors with significant biotechnology/pharmaceutical experience. The Company Cel Sci Corp is a small, Immunology based biotech with a small pipeline outside of Multikine. 41 million shares outstanding with only State Street, BlackRock and Vanguard having ~5% stakes. Extremely oversold with massive short...
Disclaimer Not financial advice, I literally wrote that gold is worthless if everyone just decides it to be so. However, I put some effort into showing what I see what I look at the action. Everything is in the picture. TradingView fix your shit so I could have done this better. Never think the shorts have to cover, Freddie Mac and Fannie Mae are proof of...
DISCLAIMER I am financially invested in this stock, I have 4200 shares, and a considerable amount of calls for an unspecified date and amount. So yes, I, in a very big way, am selling you. I financially benefit if you, the investigative reader, buy CVM shares or, very possibly, calls. That means that this is not financial advice, this is a sales pitch, so if you...
As always, I am not an analyst in any shape, form or capacity, except for shapes, forms and capacities. I am a complete stranger on the internet spewing absolute nonsense, please double check everything I post (I will add links when I have enough reputation). Ok, with the formalities out of the way, let us get down to business. I am going to follow procedure by...
High short float double top on price chart tightening range of price Ascending triangle
Short term trend lines are crossing over as did the MACD. The RSI is still low considering the move up in the last week or so. Yesterday's candle tested 3 fibonacci levels to close near the hod and above the .61 fib level. In addition the current price is still relatively close to the POC line (YTD) I anticipating a strong move to the upside based on the chart...